Radcliffe Cardiology’s journals aim to support the continuous medical education of both specialist and general cardiologists. We publish balanced and comprehensive review articles written by leading authorities, addressing the most pertinent developments in their field. Our authors benefit from:
All research published in our portfolio of journals is open access which means the version of record (VOR) is freely accessible to everyone across the globe immediately upon publication. As an author you retain all non-commercial rights for articles published under the Creative Commons Attribution Non-commercial CC-BY-NC 4.0 license, allowing users to read, download, copy, redistribute and make derivative works for non-commercial purposes, provided the original work is cited correctly.
We are committed to the highest standards of peer review. All of our journals follow a rigorous double-blind peer review process that is conducted independently and treated confidentially. All articles and the peer review comments received are evaluated by the Editor-in-Chief before they make their decision.
On average, articles submitted to our journals receive their first decision in 6 weeks of submission, ensuring rapid review whilst maintaining high quality, rigorous peer review.
In order to maximise the reach and impact of your research, we are committed to ensuring every article we publish is promoted as widely as possible. Along with open access, which supports increased readership and citations with no barriers to access, our marketing team with their SEO expertise, will ensure your research is visible to the widest possible audience, including marketing through our social and email channels to our global community of 100,000+ registered recipients.
We regularly collaborate with some of the leading societies and associations within the cardiology and vascular communities across our initiatives and activities. Within our journals portfolio, Arrhythmia & Electrophysiology Review is the official journal of the British Heart Rhythm Society (BHRS) and European Cardiology Review has an official partnership with the International Society of Cardiovascular Pharmacotherapy (ISCP).
In addition to being available through our journal websites, your research will also be available through other major full-text repositories, with journals indexed in the following repositories:
Arrhythmia & Electrophysiology Review: PubMed, PubMed Central, Crossref, Emerging Sources Citation Index (ESCI), Scopus, and the Directory of Open Access Journals (DOAJ)
Cardiac Failure Review: PubMed, PubMed Central, Crossref, Scopus and the Directory of Open Access Journals (DOAJ)
European Cardiology Review: PubMed, PubMed Central, Crossref, Emerging Sources Citation Index (ESCI), Scopus, and the Directory of Open Access Journals (DOAJ)
Interventional Cardiology Review: PubMed, PubMed Central, Crossref, Scopus, and the Directory of Open Access Journals (DOAJ)
US Cardiology Review: Scopus and the Directory of Open Access Journals (DOAJ)
Vascular & Endovascular Review: the Directory of Open Access Journals (DOAJ)
If you are interested in submitting an article, please visit the journals Author Guidelines page for more information.